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Compared with 
intermittent 
auscultation, 
continuous 
electronic fetal 
monitoring 
reduces the risk 
of neonatal 
seizure by 50%. 
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EvidEncE-basEd answEr
A	 	 continuous	 electronic	 fetal		 	 monitoring	(efm)		reduces	the	
risk	of	neonatal	seizure	by	50% com-
pared with intermittent auscultation (IA) 
(strength of recommendation [SOR]: A, 
systematic review of randomized con-
trolled trials [RCTs]). 
EFM increases the incidence of cesarean 
section by 66% and the incidence of opera-
tive vaginal delivery by 16% (SOR: A, sys-
tematic review of RCTs). It has no effect on 
the rates of cerebral palsy or neonatal mor-
tality (SOR: A, systematic review of RCTs).
An estimate from a Cochrane meta-anal-
ysis suggests that a cohort of 628 women re-
ceiving EFM could expect to experience 
1 less neonatal seizure and 11 more cesar-
ean sections compared with IA controls.
 How does electronic fetal 
heart rate monitoring affect 
labor and delivery outcomes?
Evidence summary 
Continuous EFM is designed to detect early 
fetal hypoxia and thereby decrease neonatal 
morbidity and mortality compared with IA. IA 
is defined as auscultation of the fetal heart rate 
for at least 60 seconds every 15 minutes during 
the first stage of labor and every 5 minutes dur-
ing the second stage of labor.
A decrease in seizures, but not deaths  
or cerebral palsy
A 2006 Cochrane systematic review examined 
12 RCTs (with >37,000 women) that compared 
continuous EFM with IA.1 Continuous EFM re-
duced the risk of neonatal seizure by 50% (rela-
tive risk [RR]=0.50; 95% confidence interval [CI], 
0.31-0.80), but had no effect on the rate of neo-
natal death (RR=0.85; 95% CI, 0.59-1.23) or de-
velopment of cerebral palsy (RR=1.74; 95% CI, 
0.97-3.11).  
Reduction of seizures was consistent 
across all trials. However, a subgroup analysis 
of high-risk pregnancies (advanced maternal 
age, diabetes mellitus, chronic hypertension, 
renal disease, preeclampsia, cardiac disease, 
renal disease, previous delivery of a low-birth-
weight infant) didn’t find a statistically signifi-
cant decrease in seizures. 
Cesarean deliveries rise,  
regardless of patient risk status 
Continuous EFM raised the rates of cesarean 
delivery (RR=1.66; 95% CI, 1.30-2.13) and in-
strumental vaginal deliveries (RR=1.16; 95% 
CI, 1.01-1.32). The increased rate of cesarean 
section in the EFM group was consistent re-
gardless of clinical risk status (low- vs high-
risk women). One additional cesarean section 
was performed for every 58 women moni-
tored continuously. For “high-risk” women, 
1 additional cesarean section was performed 
for every 12 women monitored continuously.1 
Cesarean section rates varied widely 
among the individual trials (2.3%-35%). Analysis 
suggested that studies with higher baseline rates 
showed the greatest increases with continu-
ous EFM. The rate for all studies combined was 
just 4.3%; 69% of patients included in the meta- 
analysis were contributed by the Dublin trial, 
which had an average cesarean rate of 2.3%.1 By 
comparison, the US Division of Vital Statistics 
reported a cesarean rate of 32.3% in 2008.2
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monitoring 
increases the 
incidence of 
cesarean section 
by 66% and 
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EFM reduces death from fetal hypoxia
A 1995 meta-analysis, including 9 of the 
Cochrane review studies with a total of 18,561 
women, evaluated the additional outcome of 
death resulting from fetal hypoxia.3 Compared 
with IA, EFM was associated with a 59% re-
duction in death from fetal hypoxia (RR=0.41; 
95%  CI, 0.17-0.98).   Continuous EFM prevented 
1 perinatal death per 1000 births. The reduc-
tion in perinatal mortality was offset by a 
53% increase in cesarean deliveries and a 
23% increase in operative vaginal deliveries.3 
Recommendations 
The American College of Obstetricians and 
Gynecologists (ACOG) doesn’t recommend 
for or against continuous fetal heart rate 
monitoring in uncomplicated labor, rec-
ognizing either EFM or IA as acceptable 
in uncomplicated patients.4 ACOG does 
recommend continuous EFM for women 
with high-risk conditions (suspected fetal 
growth restriction, preeclampsia, and type 1 
diabetes mellitus). 
The US Preventive Services Task Force 
doesn’t support routine intrapartum EFM for 
low-risk woman. The Task Force found insuf-
ficient evidence for using EFM in high-risk 
pregnancies.5 
The Royal College of Obstetricians and 
Gynaecologists and the Royal Australian and 
New Zealand College of Obstetricians and 
Gynecologists both recommend continuous 
EFM for high-risk women and IA for low-risk 
patients.6,7                          JFP
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